Reported 0 shares, down 139,900 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
|
This position's reported history falls outside the five-year preview window. A free account unlocks it.
Unlock full history
|
|||||||
Who else reported the position
106 managers reported CORBUS PHARMACEUTICALS HLDG for Q4 2019.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| ETF MANAGERS GROUP LLC | Reduced | 5,779,642 | -1,109,718 | 1.1% | $31,557,000 | 9 qtrs |
| BlackRock Inc | Reduced | 5,412,203 | -5,341 | < 0.01% | $29,551,000 | 12 qtrs |
| Knoll Capital Management LLC | Added | 5,045,870 | +60,000 | 20.34% | $27,550,000 | 19 qtrs |
| VANGUARD GROUP INC | Added | 3,221,097 | +79,796 | < 0.01% | $17,587,000 | 19 qtrs |
| STATE STREET CORPORATION | Added | 1,121,673 | +22,166 | < 0.01% | $6,124,000 | 14 qtrs |
| FMR LLC | Unchanged | 952,867 | 0 | < 0.01% | $5,203,000 | 13 qtrs |
| MORGAN STANLEY | Reduced | 785,838 | -118,749 | < 0.01% | $4,290,000 | 19 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 779,955 | +33,743 | < 0.01% | $4,258,000 | 18 qtrs |
| NORTHERN TRUST CORPORATION | Added | 695,751 | +4,497 | < 0.01% | $3,799,000 | 19 qtrs |
| D E Shaw & Co Inc | Reduced | 675,153 | -63,957 | < 0.01% | $3,686,000 | 5 qtrs |
Filing details and methodology As reported
- Report period
- December 31, 2019
- Filed
- February 14, 2020
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.